AstraZeneca PLC vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
7.5
Bullish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
AZN
High-quality business with 23% return on equity and 17% profit margins.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $223.79 (+21.1%)
10 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
AZN
PFE
27.9×
Trailing P/E
19.4×
23.7×
Forward P/E
9.4×
17.2%
Profit Margin
12.4%
81.5%
Gross Margin
75.8%
23.5%
ROE
8.9%
12.5%
Revenue Growth
-1.2%
5.3%
Earnings Growth
—
0.28
Beta
0.39
—
Price / Book
—
$286.4B
Market Cap
$149.8B
$132 – $213
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →